Who Paid My Doc
Tiffini Reedy
Nurse Practitioner, Adult Health Fall River, MA Nurse Practitioner
NPI 1891128708 CMS profile 10766182
1700 President Ave, Fall River, MA 02720
General payments
$58,116
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Tiffini Reedy of Fall River, MA is reported in the CMS Open Payments database as having received $58,116 across 220 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Nurse Practitioner, Adult Health profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $55,328 | 101 | |
| 2024 | General | $856 | 38 | |
| 2023 | General | $941 | 38 | |
| 2022 | General | $429 | 24 | |
| 2021 | General | $562 | 19 |
Beside peers
- Tiffini Reedy
- Nurse Practitioner, Adult Health median
- Middle half of Nurse Practitioner, Adult Health
- National median
In program year 2025, general payments to Tiffini Reedy were reported at $55,328. Among 12,696 Nurse Practitioner, Adult Health profiles paid that year, the median was $184 and the middle half received between $59 and $580.
Show as a table
| Year | Tiffini Reedy | Nurse Practitioner, Adult Health median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $562 | $138 | $43–$438 | $132 |
| 2022 | $429 | $165 | $54–$494 | $149 |
| 2023 | $941 | $178 | $61–$549 | $160 |
| 2024 | $856 | $186 | $62–$575 | $164 |
| 2025 | $55,328 | $184 | $59–$580 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 48 drugsPart D claims
2,910
Drug cost
$1,118,938
Branded share of claims
21.4%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Invega Sustenna Paliperidone Palmitate | Brand | 141 | $443,081 | |
| Austedo Deutetrabenazine | Brand | 67 | $367,706 | |
| Invega Trinza Paliperidone Palmitate | Brand | 13 | $119,409 | |
| Abilify Maintena Aripiprazole | Brand | 23 | $67,030 | |
| Abilify Asimtufii Aripiprazole | Brand | 12 | $64,657 | |
| Clozapine | Generic | 317 | $10,360 | |
| Aripiprazole | Generic | 111 | $8,533 | |
| Divalproex Sodium Er Divalproex Sodium | Brand | 181 | $4,760 | |
| Atomoxetine Hcl | Generic | 50 | $2,335 | |
| Olanzapine | Generic | 128 | $2,249 |
The 10 drugs with the highest cost, of 48 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.
Payments and prescribing
First 5 of 10 products · payments 2024Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.
| Product | Paid by | Related payments | Part D claims | Part B services |
|---|---|---|---|---|
| INVEGA SUSTENNA |
|
$238 | 141 | — |
| Austedo XR |
|
$201 | 67 | — |
| CAPLYTA |
|
$102 | — | — |
| ABILIFY ASIMTUFII |
|
$72 | 12 | — |
| REXULTI |
|
$64 | — | — |
A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.
See all 10 in the dashboard with a free accountRecords
220 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Nurse Practitioner, Adult Health in Massachusetts
Krista Tucker
Nurse Practitioner, Adult Health · Boston, MA
Kathleen Dietz Lovett
Nurse Practitioner, Adult Health · Hyannis, MA
Caitlin Reen
Nurse Practitioner, Adult Health · Charlestown, MA
Christine Agius
Nurse Practitioner, Adult Health · Boston, MA
Amy Pierre
Nurse Practitioner, Adult Health · Jamaica Plain, MA
Josie Bazemore
Nurse Practitioner, Adult Health · Boston, MA
Related records
Nurse Practitioner, Adult Health in Massachusetts
Practitioners in the same specialty and state, ranked by reported value.
All Nurse Practitioner, Adult Health
Everyone recorded under this specialty, nationwide.
Doctors in Massachusetts
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.